Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIP: Submucosal Corticosteroid Injection in Symptomatic Pulpitis
NCT07704398Completed
- Sponsor
- Medipol Mega University Hospital
- Start
- Oct 2023
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised trial of betamethasone and gentamicin in irreversible pulpitis (2 arms), sponsored by Medipol Mega University Hospital. Primary endpoint: Gingival Crevicular Fluid Matrix Metalloproteinase-9 Concentration at Day 3. Started Oct 2023; status: completed.
02
Drugs
betamethasonegentamicin
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07704398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704398.